Comparison of Creatinine and Specific Gravity for Hydration Corrections on Measurement of the Tobacco-Specific Nitrosamine 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol (NNAL) in Urine

被引:17
|
作者
Xia, Yang [1 ]
Wong, Lee-Yang [1 ]
Bunker, Brandon C. [2 ]
Bernert, John T. [1 ]
机构
[1] Ctr Dis Control & Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA
[2] Univ Louisville, Sch Med, Abell Adm Ctr, Louisville, KY 40292 USA
关键词
tobacco-specific nitrosamine; 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL); creatinine; specific gravity; DIETARY-SUPPLEMENT USE; NATIONAL-HEALTH; US POPULATION; SECONDHAND SMOKE; EXPOSURE; VALUES; LUNG; NORMALIZATION; CARCINOGEN; ADJUSTMENT;
D O I
10.1002/jcla.21693
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) was measured in all participants aged 6 years and older from the Centers for Disease Control and Prevention's National Health and Nutrition Examination Survey 2007-2008. The suitability of using creatinine or specific gravity for urinary NNAL correction in exposure assessment is examined in this study. Methods: Effects of both specific gravity and creatinine correction on urinary NNAL among smokers were investigated with multiple linear regression models using either normalization or the fitting of creatinine and specific gravity in the model as covariates. Results: When log-scaled NNAL was normalized by either creatinine or specific gravity, R-2 was slightly higher for creatinine than for specific gravity (R-2 = 0.1694 and 0.1439, for creatinine and specific gravity, respectively). When log-scaled NNAL was normalized by both factors, the R-2 was improved (R-2 = 0.2068). When specific gravity or creatinine was included as a covariate separately in the models, they were highly significant factors (P < 0.001, R-2 = 0.2226 and 0.1681 for creatinine and specific gravity, respectively). However, when both were included in the model as covariates, creatinine remained highly significant (P < 0.001), whereas the significance of specific gravity was eliminated (P = 0.4294). Conclusion: This study confirms significant relationships between NNAL concentrations and both urine creatinine and specific gravity. We conclude that creatinine is the more influential and preferred variable to account for urine dilution in tobacco-specific nitrosamine exposure assessment. (C) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:353 / 363
页数:11
相关论文
共 50 条
  • [31] TRANSPLACENTAL INDUCTION OF PANCREAS TUMORS IN HAMSTERS BY ETHANOL AND THE TOBACCO-SPECIFIC NITROSAMINE 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE
    SCHULLER, HM
    JORQUERA, R
    REICHERT, A
    CASTONGUAY, A
    CANCER RESEARCH, 1993, 53 (11) : 2498 - 2501
  • [32] Adsorption of tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone from aqueous solution with graphene aerogel
    Xu, T. G.
    Shi, R.
    Lu, N.
    Zhang, J.
    Bai, R. S.
    Yang, Z. D.
    Zhou, J.
    2017 5TH INTERNATIONAL CONFERENCE ON MECHANICAL ENGINEERING, MATERIALS SCIENCE AND CIVIL ENGINEERING, 2018, 324
  • [33] Absolute configuration of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol formed metabolically from 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
    Hecht, SS
    Spratt, TE
    Trushin, N
    CARCINOGENESIS, 1997, 18 (09) : 1851 - 1854
  • [34] Stereospecific deuterium substitution attenuates the tumorigenicity and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)
    Jalas, JR
    McIntee, EJ
    Kenney, PMJ
    Upadhyaya, P
    Peterson, LA
    Hecht, SS
    CHEMICAL RESEARCH IN TOXICOLOGY, 2003, 16 (06) : 794 - 806
  • [35] Tobacco-specific carcinogen nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induces AKT activation in head and neck epithelia
    Weber, Stephen M.
    Bornstein, Sophia
    Li, Yuexin
    Malkoski, Stephen P.
    Wang, Donna
    Rustgi, Anil K.
    Kulesz-Martin, Molly F.
    Wang, Xiao-Jing
    Lu, Shi-Long
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 39 (05) : 1193 - 1198
  • [36] METABOLISM OF THE TOBACCO-SPECIFIC NITROSAMINE 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE IN THE PATAS MONKEY - PHARMACOKINETICS AND CHARACTERIZATION OF GLUCURONIDE METABOLITES
    HECHT, SS
    TRUSHIN, N
    REIDQUINN, CA
    BURAK, ES
    JONES, AB
    SOUTHERS, JL
    GOMBAR, CT
    CARMELLA, SG
    ANDERSON, LM
    RICE, JM
    CARCINOGENESIS, 1993, 14 (02) : 229 - 236
  • [37] Carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in cytosol of mouse liver and lung
    Atalla, A
    Maser, E
    TOXICOLOGY, 1999, 139 (1-2) : 155 - 166
  • [38] THE TOBACCO-SPECIFIC NITROSAMINE 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE IS AN ACTIVE TRANSPLACENTAL CARCINOGEN IN SYRIAN GOLDEN-HAMSTERS
    CORREA, E
    JOSHI, PA
    CASTONGUAY, A
    SCHULLER, HM
    CANCER RESEARCH, 1990, 50 (11) : 3435 - 3438
  • [39] Metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in the urine of newborns.
    Hecht, SS
    Carmella, SG
    Chen, ML
    Salzberger, U
    Tollner, U
    Lackmann, GM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U555 - U555
  • [40] Disposition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in bile duct-cannulated rats: Stereoselective metabolism and tissue distribution
    Wu, Z
    Upadhyaya, P
    Carmella, SG
    Hecht, SS
    Zimmerman, CL
    CARCINOGENESIS, 2002, 23 (01) : 171 - 179